Imprimis recalls specific ophthalmic solution due to subpotent drug levels. This may not work as intended for eye treatments. Check your product details to see if affected.
Sub-Potent Drug: Subpotent assay results during stability testing.
Imprimis is recalling a specific ophthalmic solution that may have lower-than-stated drug levels. This could mean the medication isn't effective for treating eye conditions. Affected users should check their product details and contact the manufacturer.
The solution may have lower-than-stated drug concentrations due to stability testing issues. This could lead to the medication not working properly when used for eye treatments.
People who have the specific ophthalmic solution with NDC 71384-733-05 and lot number 25MAR032. Those using the product for eye treatments are most at risk.
Check for the product name 'Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton' with NDC 71384-733-05 and lot number 25MAR032.
Look for the NDC code 71384-733-05 and lot number 25MAR032 on the product packaging.
The recall states the product may have lower-than-stated drug levels, but it is not unsafe for use. However, it may not work as intended for eye treatments.
The recall does not specify a remedy, so check the product details and contact Imprimis if you have concerns.
Look for the NDC code 71384-733-05 and lot number 25MAR032 on the product packaging.
We’ve drafted a message you can send Imprimis to request your refund or repair — edit it as you like.
Subject: Recall D-0536-2025 — Imprimis Imprimis Hello, I own a Imprimis that is covered by recall D-0536-2025 from Imprimis. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
